Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Testisin, a glycosyl-phosphatidylinositol-linked serine protease, promotes malignant transformation in vitro and in vivo.

Tang T, Kmet M, Corral L, Vartanian S, Tobler A, Papkoff J.

Cancer Res. 2005 Feb 1;65(3):868-78.

2.

The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.

Salceda S, Tang T, Kmet M, Munteanu A, Ghosh M, Macina R, Liu W, Pilkington G, Papkoff J.

Exp Cell Res. 2005 May 15;306(1):128-41.

PMID:
15878339
3.

Overexpression of testisin, a serine protease expressed by testicular germ cells, in epithelial ovarian tumor cells.

Shigemasa K, Underwood LJ, Beard J, Tanimoto H, Ohama K, Parmley TH, O'Brien TJ.

J Soc Gynecol Investig. 2000 Nov-Dec;7(6):358-62.

PMID:
11111072
4.

Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells.

Gery S, Xie D, Yin D, Gabra H, Miller C, Wang H, Scott D, Yi WS, Popoviciu ML, Said JW, Koeffler HP.

Clin Cancer Res. 2005 Oct 15;11(20):7243-54.

6.

Interaction of testisin with maspin and its impact on invasion and cell death resistance of cervical cancer cells.

Yeom SY, Jang HL, Lee SJ, Kim E, Son HJ, Kim BG, Park C.

FEBS Lett. 2010 Apr 16;584(8):1469-75. doi: 10.1016/j.febslet.2010.02.072. Epub 2010 Mar 6.

7.

B7-H4 expression promotes tumorigenesis in ovarian cancer.

Cheng L, Jiang J, Gao R, Wei S, Nan F, Li S, Kong B.

Int J Gynecol Cancer. 2009 Dec;19(9):1481-6. doi: 10.1111/IGC.0b013e3181ad0fa2.

PMID:
19955922
8.

Stable lower PAR expression decreased DU145 prostate cancer cell growth in SCID mice.

Platica M, Ivan E, Chen S, Holland JF, Gil J, Mandeli J, Platica O.

Prostate. 2001 Nov 1;49(3):200-7.

PMID:
11746265
9.

Cloning, expression analysis, and tissue distribution of esp-1/testisin, a membrane-type serine protease from the rat.

Nakamura Y, Inoue M, Okumura Y, Shiota M, Nishikawa M, Arase S, Kido H.

J Med Invest. 2003 Feb;50(1-2):78-86.

PMID:
12630572
10.

CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability.

Fraser MM, Watson PM, Fraig MM, Kelley JR, Nelson PS, Boylan AM, Cole DJ, Watson DK.

Cancer Res. 2005 Jul 15;65(14):6228-36.

12.

Hepsin shows inhibitory effects through apoptotic pathway on ovarian cancer cell lines.

Nakamura K, Nasu Y, Hongo A, Matsuo T, Kodama J, Ebara S, Nagai A, Abrzua F, Kumon H, Hiramatsu Y.

Int J Oncol. 2006 Feb;28(2):393-8.

PMID:
16391794
13.

Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells.

Lai D, Ma L, Wang F.

Int J Oncol. 2012 Aug;41(2):541-50. doi: 10.3892/ijo.2012.1475. Epub 2012 May 14.

PMID:
22614695
14.

Tumor promoting properties of the ETS protein MEF in ovarian cancer.

Yao JJ, Liu Y, Lacorazza HD, Soslow RA, Scandura JM, Nimer SD, Hedvat CV.

Oncogene. 2007 Jun 7;26(27):4032-7. Epub 2007 Jan 8.

PMID:
17213815
16.

Small interfering RNA against PTTG: a novel therapy for ovarian cancer.

El-Naggar SM, Malik MT, Kakar SS.

Int J Oncol. 2007 Jul;31(1):137-43.

PMID:
17549414
17.

RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitroand in vivo.

Zhang X, Deng HX, Zhao X, Su D, Chen XC, Chen LJ, Wei YQ, Zhong Q, Li ZY, He X, Yi T.

Oncology. 2009;77(1):22-32. doi: 10.1159/000218201. Epub 2009 May 12.

PMID:
19440000
18.

Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.

Yang G, Rosen DG, Mercado-Uribe I, Colacino JA, Mills GB, Bast RC Jr, Zhou C, Liu J.

Carcinogenesis. 2007 Jan;28(1):174-82. Epub 2006 Jul 8.

PMID:
16829690
19.

Downregulation of HtrA1 promotes resistance to anoikis and peritoneal dissemination of ovarian cancer cells.

He X, Ota T, Liu P, Su C, Chien J, Shridhar V.

Cancer Res. 2010 Apr 15;70(8):3109-18. doi: 10.1158/0008-5472.CAN-09-3557. Epub 2010 Apr 13.

20.

Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer.

Popadiuk CM, Xiong J, Wells MG, Andrews PG, Dankwa K, Hirasawa K, Lake BB, Kao KR.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2216-23.

Supplemental Content

Support Center